Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment

Por um escritor misterioso

Descrição

Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Molecular and cellular paradigms of multidrug resistance in cancer
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Role of natural P-gp inhibitor in the effective delivery for
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Frontiers Perplexing Role of P-Glycoprotein in Tumor
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Incorporation of drug efflux inhibitor and chemotherapeutic agent
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Targeting epigenetic regulators to overcome drug resistance in
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Cancers, Free Full-Text
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Advances in understanding the role of P-gp in doxorubicin
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
A targeted nanoplatform co-delivery of pooled siRNA and
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Frontiers Cancer Stem Cells as a Potential Target to Overcome
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Multidrug resistance in cancer: role of ATP–dependent transporters
de por adulto (o preço varia de acordo com o tamanho do grupo)